Combo immunotherapy may herald new standard of care for kidney cancer

Go to article

Posted by on July 5, 2017 10:28 pm
Tags:
Categories: health

Combination therapy with two immunotherapy drugs produces an unprecedented doubling of response rates from 20 percent to 40 percent, a new study shows.

Leave a Reply

Your email address will not be published. Required fields are marked *

< Buzz Post home